From in vitro to ex vivo: subcellular localization and uptake of graphene quantum dots into solid tumors

David Kersting,Stefan Fasbender,Rabea Pilch,Jennifer Kurth,André Franken,Marina Ludescher,Johanna Naskou,Angelika Hallenberger,Charlotte von Gall,Corinna J Mohr,Robert Lukowski,Katharina Raba,Sandra Jaschinski,Irene Esposito,Johannes C Fischer,Tanja Fehm,Dieter Niederacher,Hans Neubauer,Thomas Heinzel
DOI: https://doi.org/10.1088/1361-6528/ab2cb4
IF: 3.5
2019-09-27
Nanotechnology
Abstract:Among various nanoparticles tested for pharmacological applications over the recent years, graphene quantum dots (GQDs) seem to be promising candidates for the construction of drug delivery systems due to their superior biophysical and biochemical properties. The subcellular fate of incorporated nanomaterial is decisive for transporting pharmaceuticals into target cells. Therefore a detailed characterization of the uptake of GQDs into different breast cancer models was performed. The demonstrated accumulation inside the endolysosomal system might be the reason for the particles' low toxicity, but has to be overcome for cytosolic or nuclear drug delivery. Furthermore, the penetration of GQDs into precision-cut mammary tumor slices was studied. These constitute a far closer to reality model system than monoclonal cell lines. The constant uptake into the depth of the tissue slices underlines the systems' potential for drug delivery into solid tumors.
What problem does this paper attempt to address?